<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>36</volume><submitter>Stajer K</submitter><pubmed_abstract>Phosphoribosylpyrophosphate synthetase 1 (PRS-I) is an enzyme involved in nucleotide metabolism. Pathogenic variants in the &lt;i>PRPS1&lt;/i> are rare and PRS-I deficiency can manifest as three clinical syndromes: X-linked non-syndromic sensorineural deafness (DFN2), X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5) and Arts syndrome. We present a Slovenian patient with PRS-I enzyme deficiency due to a novel pathogenic variant - c.424G > A (p.Val142Ile) in the &lt;i>PRPS1&lt;/i> gene, who presented with gross motor impairment, severe sensorineural deafness, balance issues, ataxia, and frequent respiratory infections. In addition, we report the findings of a systemic literature review of all described male cases of Arts syndrome and CMTX5 as well as intermediate phenotypes. As already proposed by other authors, our results confirm PRS-I deficiency should be viewed as a phenotypic continuum rather than three separate syndromes because there are multiple reports of patients with an intermediary clinical presentation.</pubmed_abstract><journal>Molecular genetics and metabolism reports</journal><pagination>100986</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10475845</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Clinical and genetic characteristics of a patient with phosphoribosyl pyrophosphate synthetase 1 deficiency and a systematic literature review.</pubmed_title><pmcid>PMC10475845</pmcid><pubmed_authors>Mlinaric M</pubmed_authors><pubmed_authors>Debeljak M</pubmed_authors><pubmed_authors>Zver A</pubmed_authors><pubmed_authors>Battelino T</pubmed_authors><pubmed_authors>Kovac N</pubmed_authors><pubmed_authors>Brecelj J</pubmed_authors><pubmed_authors>Drole Torkar A</pubmed_authors><pubmed_authors>Jimenez Torres R</pubmed_authors><pubmed_authors>Bertok S</pubmed_authors><pubmed_authors>Kovac J</pubmed_authors><pubmed_authors>Rus R</pubmed_authors><pubmed_authors>Sikonja J</pubmed_authors><pubmed_authors>Groselj U</pubmed_authors><pubmed_authors>Markelj G</pubmed_authors><pubmed_authors>Neubauer D</pubmed_authors><pubmed_authors>Stajer K</pubmed_authors><pubmed_authors>Zerjav Tansek M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical and genetic characteristics of a patient with phosphoribosyl pyrophosphate synthetase 1 deficiency and a systematic literature review.</name><description>Phosphoribosylpyrophosphate synthetase 1 (PRS-I) is an enzyme involved in nucleotide metabolism. Pathogenic variants in the &lt;i>PRPS1&lt;/i> are rare and PRS-I deficiency can manifest as three clinical syndromes: X-linked non-syndromic sensorineural deafness (DFN2), X-linked Charcot-Marie-Tooth neuropathy type 5 (CMTX5) and Arts syndrome. We present a Slovenian patient with PRS-I enzyme deficiency due to a novel pathogenic variant - c.424G > A (p.Val142Ile) in the &lt;i>PRPS1&lt;/i> gene, who presented with gross motor impairment, severe sensorineural deafness, balance issues, ataxia, and frequent respiratory infections. In addition, we report the findings of a systemic literature review of all described male cases of Arts syndrome and CMTX5 as well as intermediate phenotypes. As already proposed by other authors, our results confirm PRS-I deficiency should be viewed as a phenotypic continuum rather than three separate syndromes because there are multiple reports of patients with an intermediary clinical presentation.</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2025-04-22T04:13:16.647Z</modification><creation>2025-04-05T20:54:17.986Z</creation></dates><accession>S-EPMC10475845</accession><cross_references><pubmed>37670898</pubmed><doi>10.1016/j.ymgmr.2023.100986</doi></cross_references></HashMap>